These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32317629)

  • 1. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1.
    Huang W; Yan Y; Liu Y; Lin M; Ma J; Zhang W; Dai J; Li J; Guo Q; Chen H; Makabel B; Liu H; Su C; Bi H; Zhang J
    Signal Transduct Target Ther; 2020 Apr; 5(1):39. PubMed ID: 32317629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.
    Liu F; Wang X; Li J; Gu K; Lv L; Zhang S; Che D; Cao J; Jin S; Yu Y
    Cell Prolif; 2015 Oct; 48(5):582-92. PubMed ID: 26250586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-768-3p is involved in the proliferation, invasion and migration of non-small cell lung carcinomas.
    Xie Z; Chen W; Chen Y; Wang X; Gao W; Liu Y
    Int J Oncol; 2017 Nov; 51(5):1574-1582. PubMed ID: 29048613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
    Zeng X; Liu D; Peng G; Liu J; Yang H
    Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jaceosidin inhibits the progression and metastasis of NSCLC by regulating miR-34c-3p/Integrin α2β1 axis.
    Guo QR; Zhou WM; Zhang GB; Deng ZF; Chen XZ; Sun FY; Lei XP; Yan YY; Zhang JY
    Heliyon; 2023 May; 9(5):e16158. PubMed ID: 37215793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
    Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
    Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p.
    Wei F; Ma C; Zhou T; Dong X; Luo Q; Geng L; Ding L; Zhang Y; Zhang L; Li N; Li Y; Liu Y
    Mol Cancer; 2017 Jul; 16(1):132. PubMed ID: 28743280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer.
    Qi Y; Zha W; Zhang W
    J BUON; 2019; 24(2):599-607. PubMed ID: 31128012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
    Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
    Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
    Wang A; Wang J
    DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.
    Chi Y; Jin Q; Liu X; Xu L; He X; Shen Y; Zhou Q; Zhang J; Jin M
    Cancer Sci; 2017 Dec; 108(12):2366-2372. PubMed ID: 28921827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-550a-3p promotes non-small cell lung cancer cell proliferation and metastasis through down-regulating TIMP2.
    Yang JZ; Bian L; Hou JG; Wang HY
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4156-4165. PubMed ID: 30024604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-381 serves as a prognostic factor and inhibits migration and invasion in non-small cell lung cancer by targeting LRH-1.
    Tian C; Li J; Ren L; Peng R; Chen B; Lin Y
    Oncol Rep; 2017 Nov; 38(5):3071-3077. PubMed ID: 29048619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
    Yang W; Zhou C; Luo M; Shi X; Li Y; Sun Z; Zhou F; Chen Z; He J
    Oncotarget; 2016 Mar; 7(13):16703-15. PubMed ID: 26934648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
    Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
    BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.